Sibel Health, a vitals-monitoring device developer, has received its first 510(k) clearance from the US Food and Drug Administration (FDA) for its vital signs monitoring platform ANNE One.
ANNE One uses its two wearable devices with embedded sensors to collect health data; Anne Limb tracks body and skin temperature while Anne Chest tracks heart rate, respiratory rate, step count, body posture, and skin temperature. The system comes with a companion mobile device pre-loaded with ANNE View software for real-time visualization of clinical data.
Spun out of Querrey Simpson Institute for Bioelectronics at Northwestern University, Illinois-based Sibel Health provides a platform to monitor vital signs. The company’s other products include Anne Care for remote patient monitoring and Anne Sleep for sleep tracking. The platform is currently available in 24 countries, including the US, and South Korea.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.